|
Real-time Estimate
Cboe BZX
13:00:24 2026-11-05 EST
|
5-day change | 1st Jan Change | ||
| 531.04 USD | -3.21% |
|
-1.73% | +24.47% |
| 11-03 | Chemed Insider Sold Shares Worth $494,196, According to a Recent SEC Filing | MT |
| 10-29 | UBS Adjusts Price Target on Chemed to $675 From $650, Keeps Buy Rating | MT |
Company Valuation: Chemed Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 8,109 | 7,590 | 8,776 | 7,909 | 6,037 | 7,110 | - | - |
| Change | - | -6.4% | 15.62% | -9.88% | -23.67% | 17.79% | - | - |
| Enterprise Value (EV) 1 | 8,109 | 7,590 | 8,776 | 7,909 | 6,037 | 7,127 | 6,832 | 6,546 |
| Change | - | -6.4% | 15.62% | -9.88% | -23.67% | 18.05% | -4.13% | -4.19% |
| P/E | 31.4x | 30.5x | 32.6x | 26.6x | 23.3x | 24.6x | 21x | 19.2x |
| PBR | - | - | - | - | - | 7.4x | 5.5x | 4.39x |
| PEG | - | -39.53x | 4.5x | 2.4x | -2.99x | 1.1x | 1.2x | 2.04x |
| Capitalization / Revenue | 3.79x | 3.56x | 3.88x | 3.25x | 2.39x | 2.6x | 2.44x | 2.31x |
| EV / Revenue | 3.79x | 3.56x | 3.88x | 3.25x | 2.39x | 2.61x | 2.34x | 2.13x |
| EV / EBITDA | 17.6x | 16.8x | 19.4x | 15.7x | 13.2x | 13.8x | 12.3x | 11.1x |
| EV / EBIT | 20x | 18.4x | 22.3x | 19.9x | 15.4x | 16.3x | 14.3x | 12.6x |
| EV / FCF | - | - | - | - | 18.5x | 22.1x | 19x | - |
| FCF Yield | - | - | - | - | 5.39% | 4.52% | 5.27% | - |
| Dividend per Share 2 | 1.4 | 1.48 | 1.56 | 1.8 | 2.2 | 2.6 | 2.855 | 2.92 |
| Rate of return | 0.26% | 0.29% | 0.27% | 0.34% | 0.51% | 0.47% | 0.52% | 0.53% |
| EPS 2 | 16.85 | 16.72 | 17.93 | 19.89 | 18.34 | 22.27 | 26.13 | 28.59 |
| Distribution rate | 8.31% | 8.85% | 8.7% | 9.05% | 12% | 11.7% | 10.9% | 10.2% |
| Net sales 1 | 2,139 | 2,135 | 2,264 | 2,431 | 2,530 | 2,734 | 2,915 | 3,074 |
| EBITDA 1 | 461.4 | 452.3 | 451.9 | 503 | 458.7 | 517.8 | 554.7 | 589.5 |
| EBIT 1 | 404.9 | 412.1 | 393.8 | 397.2 | 392.7 | 438.2 | 478.5 | 519.2 |
| Net income 1 | 268.6 | 249.6 | 272.5 | 302 | 265.2 | 307.9 | 345.3 | 362.5 |
| Net Debt 1 | - | - | - | - | - | 16.16 | -278.2 | -564.6 |
| Reference price 2 | 529.04 | 510.43 | 584.75 | 529.80 | 427.86 | 548.64 | 548.64 | 548.64 |
| Nbr of stocks (in thousands) | 15,328 | 14,870 | 15,008 | 14,928 | 14,109 | 12,960 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 2/27/24 | 2/26/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.64x | 2.61x | 13.76x | 0.47% | 7.11B | |
| 11.65x | 0.37x | 7.72x | 3.33% | 102B | |
| 16.87x | 1.99x | 9.9x | 0.61% | 107B | |
| -272.43x | 18.99x | -321.12x | -.--% | 56.36B | |
| 15.57x | 1.66x | 10.02x | 2.27% | 32.48B | |
| 27.25x | 2.37x | 13.42x | 0.79% | 29.86B | |
| 24.77x | 2.74x | 13.91x | 1.29% | 28.13B | |
| 8.03x | 1.51x | 6.67x | -.--% | 23.26B | |
| 29.44x | 5.26x | 21.55x | 2.37% | 19.9B | |
| 30.11x | 2.84x | 12.79x | 1.47% | 16.92B | |
| Average | -8.41x | 4.03x | -21.14x | 1.26% | 42.3B | |
| Weighted average by Cap. | -21.02x | 4.09x | -33.66x | 1.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CHE Stock
- Valuation Chemed Corporation
Select your edition
All financial news and data tailored to specific country editions
